Clinical trial
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic…
NCT00219544 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00219544 |
|---|---|
| Title | Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. |
| Official title | A Randomized, Placebo-Controlled Trial of the Efficacy and Safety of Pregabalin in the Treatment of Subjects With Peripheral Neuropathic Pain |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neuropathic Pain |
| Intervention type | Drug |
| Interventions | Pregabalin (Lyrica), Placebo |
| Enrollment | 158 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 22, 2021 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: